Market research
000538.SHE Yunnan Baiyao Group Co.,Ltd
SHE CNY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 90B
- P/E ratio
- 17.26
- Analyst target
- 68.055
- Dividend yield
- 3.1%
- Beta
- 0.09
Profile
Company facts
- Exchange
- SHE
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CNE0000008X7
- Market cap
- 90B
- P/E ratio
- 17.26
- Analyst target
- 68.055
- Dividend yield
- 3.1%
- Beta
- 0.09
About
About Yunnan Baiyao Group Co.,Ltd
Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China. The company offers health products; traditional Chinese medicine used for pain management and anti-inflammation, including the Yunnan Baiyao aerosol, Yunnan Baiyao ointment, and Yunnan Baiyao band-aid; generic drugs and natural specialty medicines in various areas, such as physical fitness, respiratory ailments, cardiovascular health, gynecology, pediatrics, and others; medical devices; tea products; and pharmaceutical supply chain service solutions. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 000538.SHE discussion.
5 years, 5 months ago
Yunnan Baiyao Group Co.,Ltd is currently in a long term downtrend where the price is trading 6.7% below its 200 day moving average.
From a valuation standpoint, the stock is 50.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
Yunnan Baiyao Group Co.,Ltd's total revenue rose by 9.9% to $9B since the same quarter in the previous year.
Its net income has increased by 96.8% to $1B since the same quarter in the previous year.
Finally, its free cash flow fell by 89.2% to $192M since the same quarter in the previous year.
Based on the above factors, Yunnan Baiyao Group Co.,Ltd gets an overall score of 3/5.